Peptide oligomers have detrimental metabolic effects and cause pro-arrhythmic electrophysiological changes in heart atria, suggesting they may contribute to atrial fibrillation.
A particular anti-arrhythmia drug provides a targeted treatment for certain forms of atrial fibrillation.
Accessibility Tools